Actively Recruiting

Phase Not Applicable
Age: 35Years +
All Genders
NCT04252781

Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-01-09

300

Participants Needed

1

Research Sites

287 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Chronic Obstructive Pulmonary Disease (COPD), , secondary to smoking, is a major public health issue with very high direct and indirect costs. The impact on the health system of undiagnosed patients, up to 70% of patients, is increasingly documented. However, systematic spirometry screening remains controversial among smokers in the absence of data to link the detection of new patients with improved management and clinical events and health goals. More generally, there is little data on the evolution of patients in real life once they have entered the care system. The premise is that with systematic screening in general medicine, it is possible to identify the evolution of newly diagnosed COPD patients, to distinguish the different possible evolutions according to the initial phenotype and the management.

CONDITIONS

Official Title

Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

Who Can Participate

Age: 35Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age over 35 years
  • Smoking history of more than 20 pack-years
  • Current active smoker or quit less than 1 month ago
  • Signed consent to participate in Phase I of the study
  • For patients with incidental COPD: FEV1/FVC less than 70% of predicted value and/or less than the lower limit of normal
  • Signed consent to participate in Phase II of the study
Not Eligible

You will not qualify if you...

  • Previously known COPD diagnosis
  • Currently receiving treatment for cancer
  • No affiliation with social security or social protection scheme
  • Pregnant or breastfeeding women
  • Patients deprived of liberty or under legal protection (such as guardianship or curatorship)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hopital Henri MONDOR

Créteil, Île-de-France Region, France, 94000

Actively Recruiting

Loading map...

Research Team

L

Laurent BOYER, MD

CONTACT

L

Lila KACI

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here